Ithaka Group LLC Dexcom Inc Transaction History

Ithaka Group LLC

$541 Million
Q2 2024

A detailed history of Ithaka Group LLC transactions in Dexcom Inc stock. As of the latest transaction made, Ithaka Group LLC holds 118,657 shares of DXCM stock, worth $8.25 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares

118,657

Previous 119,542 0.74%

Holding current value

$8.25 Million

Previous $16.6 Million 18.86%

% of portfolio

2.49%

Previous 3.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$110.31 - $140.45 $97,624 - $124,298	-885 Reduced 0.74%	118,657 $13.5 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $976,695 - $1.2 Million	8,551 Added 7.7%	119,542 $16.6 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $159,736 - $262,722	-2,116 Reduced 1.87%	110,991 $13.8 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $346,219 - $554,892	-4,023 Reduced 3.43%	113,107 $10.6 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $2.32 Million - $2.71 Million	-20,660 Reduced 14.99%	117,130 $15.1 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $16.8 Million - $19.8 Million	-161,204 Reduced 53.92%	137,790 $16 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $11.2 Million - $16.1 Million	131,269 Added 78.26%	298,994 $33.9 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $149,035 - $183,839	-1,952 Reduced 1.15%	167,725 $13.5 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $8.51 Million - $16.6 Million	125,131 Added 280.9%	169,677 $12.6 Million
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $9,596 - $13,280	102 Added 0.23%	44,546 $22.8 Million
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $116,623 - $146,212	-898 Reduced 1.98%	44,444 $23.9 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $155,903 - $209,185	-1,461 Reduced 3.12%	45,342 $24.8 Million
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $43,734 - $58,282	-540 Reduced 1.14%	46,803 $20 Million
Q1 2021 May 06, 2021	SELL	$84.79 - $104.74 $661,701 - $817,390	-7,804 Reduced 14.15%	47,343 $17 Million
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $42,354 - $56,743	543 Added 0.99%	55,147 $20.4 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $15,663 - $18,523	-164 Reduced 0.3%	54,604 $22.5 Million
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $3,196 - $5,372	51 Added 0.09%	54,768 $22.2 Million
Q1 2020 May 11, 2020	SELL	$47.79 - $75.63 $66,523 - $105,276	-1,392 Reduced 2.48%	54,717 $14.7 Million
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $673,624 - $1.05 Million	-18,395 Reduced 24.69%	56,109 $12.3 Million
Q3 2019 Nov 12, 2019	BUY	$35.53 - $43.8 $250,735 - $309,096	7,057 Added 10.46%	74,504 $11.1 Million
Q2 2019 Aug 12, 2019	BUY	$27.84 - $38.92 $52,756 - $73,753	1,895 Added 2.89%	67,447 $10.1 Million
Q1 2019 May 13, 2019	BUY	$28.07 - $38.18 $1.84 Million - $2.5 Million	65,552 New	65,552 $7.81 Million

Others Institutions Holding DXCM

# of Institutions

1,111

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ithaka Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ithaka Group LLC with notifications on news.

Account